Small Molecules
Total Trials
28
As Lead Sponsor
22
As Collaborator
6
Total Enrollment
11,572
NCT00502970
Short Course of Interferon Treatment in Patients With HCV Infection
Phase: Phase 4
Role: Collaborator
Start: May 31, 2004
Completion: Nov 30, 2007
NCT00415961
Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety
Phase: N/A
Start: Nov 30, 2006
Completion: May 31, 2012
NCT02601976
Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population
Role: Lead Sponsor
Start: Aug 31, 2010
Completion: Sep 30, 2014
NCT01770483
The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients
Start: Jul 31, 2011
Completion: Mar 31, 2013
NCT02600780
Zurig (Febuxostat) 40mg Efficacy and Safety Trial
Start: Nov 30, 2013
Completion: Mar 31, 2015
NCT02375022
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Phase: Phase 2
Start: Mar 31, 2015
Completion: Mar 31, 2016
NCT03710057
Effect of Ivabradine in Lowering Heart Rate and Quality of Life in Chronic Heart Failure Patients
Start: Dec 1, 2016
Completion: May 15, 2017
NCT04301219
Knowledge and Practices of ADR Reporting in LMICs
Start: Apr 1, 2017
Completion: Dec 1, 2018
NCT03386955
BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer
Phase: Phase 1/2
Start: Aug 16, 2017
Completion: Dec 23, 2021
NCT04664894
Direct Acting Anti-Viral's In Chronic HCV Patients
Start: May 15, 2018
Completion: May 30, 2019
NCT04665284
Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus
Start: Jun 1, 2019
Completion: Sep 28, 2020
NCT03812809
A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive
Start: Jul 5, 2019
Completion: Jan 24, 2022
NCT04135833
A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711
Phase: Phase 1
Start: Dec 12, 2019
Completion: Jul 22, 2020
NCT04135820
A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711
Start: Dec 17, 2019
Completion: Mar 25, 2020
NCT05359432
Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus
Start: Jul 1, 2020
Completion: Aug 18, 2021
NCT05161741
Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus
Start: Jan 1, 2021
Completion: Nov 30, 2022
NCT05167513
Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients
Completion: Apr 28, 2022
NCT05164263
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
Start: Apr 1, 2021
Completion: Aug 31, 2027
NCT03866499
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients
Phase: Phase 3
Start: Apr 30, 2021
Completion: Dec 30, 2025
NCT04976283
Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver
Start: Sep 15, 2021
Completion: Nov 15, 2023
NCT05556291
Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study
Start: Dec 1, 2022
Completion: Dec 1, 2024
NCT05644717
Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Start: Mar 1, 2023
Completion: Dec 1, 2025
NCT05156736
Pakistan Study of Premature Coronary Atherosclerosis in Young Adults
Start: Mar 15, 2023
Completion: Nov 30, 2028
NCT05973188
Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial
Start: May 1, 2023
Completion: Jun 30, 2024
NCT05977647
Medical Stone Expulsive Therapy for Acutely Obstructed Ureteric Calculi
Start: Sep 1, 2024
Completion: Jun 30, 2025
NCT06706609
Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population
Start: Feb 1, 2025
Completion: Dec 31, 2025
NCT07031141
Diabetes Foot Africa Region Registry
Start: Aug 1, 2025
Completion: Feb 1, 2027
NCT07174297
Acotiamide vs Itopride in Postprandial Distress Syndrome
Start: Oct 30, 2025
Completion: Apr 30, 2027
Loading map...